Inotropic Support During Experimental Endotoxemic Shock: Part II. A Comparison of Levosimendan with Dobutamine
Abstract
BACKGROUND: We compared the association of levosimendan or dobutamine with norepinephrine for the maintenance of systemic and hepatosplanchnic perfusion during early endotoxemic shock. METHODS: Twenty anesthetized pigs (26.8 +/- 0.5 kg) were instrumented with flow probes and catheters to monitor systemic and regional perfusion as described in our companion article in this issue of the journal. Two animals were excluded because of surgical complications. Oxygen consumption (VO(2)) was measured by indirect calorimetry. Starting 1 h after instrumentation, an endotoxin infusion (Escherichia coli lipopolysaccharide, 2 microg x kg(-1) x h(-1)) was administered for 300 min. Sixty minutes after the start of endotoxin, the animals were fluid resuscitated (20 mL/kg dextran 70); at 120 min, they were randomized into three groups of six animals each: levosimendan (25-50 microg x kg(-1) x h(-1)), dobutamine (10-20 microg x kg(-1) x min(-1)), and control. In the first two groups, norepinephrine (0.5-2 microg x kg(-1) x min(-1)) was added when mean arterial blood pressure (MAP) or= baseline. The data were divided into two subsets: before (0-120 min, all animals) and after (120-300 min, three groups) randomization, and analyzed by analysis of variance. P < 0.05 was considered significant. RESULTS: At 120 min, cardiac output was 15% higher (P < 0.001), systemic vascular resistance was 30% lower (P < 0.001), and MAP decreased 12.5% (P = 0.004); blood flow in the hepatic artery, superior mesenteric artery, and portal vein had increased by 100% (P = 0.004), 60% (P < 0.001), and 20% (P < 0.001), respectively. Between 120 and 300 min, cardiac output and systemic oxygen delivery decreased 50% in control animals (P < 0.05), remained unchanged in the levosimendan group, and increased 60% with dobutamine (P = 0.05). MAP (P = 0.043) and VO(2) (P = 0.001) decreased 20% in the control group. Portal vein flow decreased in the control (50%) and levosimendan (30%) groups (P < 0.001) and was therefore higher in the dobutamine group (P = 0.003) at 300 min. Hepatic and gut oxygen deliveries decreased in the levosimendan (50%, and 30%, respectively, P < 0.001) and control groups (70% and 45%, respectively, P < 0.05); thus, regional oxygen deliveries were greater in the dobutamine group (P < 0.05). In this group, mixed venous and hepatic vein oxygen saturation were maintained; the latter variable was higher than in the other groups (P < 0.05). Although unchanged with dobutamine, arterial (P = 0.020), portal (P = 0.020), and hepatic vein (P = 0.034) lactate concentrations increased twofold with levosimendan. CONCLUSION: In volume-resuscitated endotoxemic pigs, the association of either levosimendan or dobutamine with norepinephrine preserved systemic blood flow, oxygen delivery, and VO(2). However, only dobutamine-norepinephrine maintained portal blood flow, which was associated with preservation of splanchnic and hepatic oxygen homeostasis and stable lactate concentrations.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Dobutamine increases cardiac output and oxygen transport, increases splanchnic perfusion and tissue oxygenation, and improves intramucosal acidosis and hyperlactatemia.
“Physiologic studies demonstrate that dobutamine increases CO and oxygen transport, increases splanchnic perfusion and tissue oxygenation, improves intramucosal acidosis and hyperlactatemia [369].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [369]
Cites
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743 · see citing works
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun‐Buisson, C., Beale, R. J., et al. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,722 · see citing works
Pathogenetic Mechanisms of Septic Shock
Epstein, F. H., & Parrillo, J. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282008 · Cited by 1,548 · see citing works
Elevation of Systemic Oxygen Delivery in the Treatment of Critically Ill Patients
Hayes, M., Timmins, A. C., Yau, E. H. S., Palazzo, M. G. A., Hinds, C., & Watson, D. I. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406163302404 · Cited by 1,530 · see citing works
Bakker, J., Coffernils, M., Leon, M., Gris, P., & Vincent, J.-L. (1991) · CHEST Journal · doi:10.1378/chest.99.4.956 · Cited by 715 · see citing works
Multiple Organ Failure Syndrome in the 1990s
Beal, A. L. (1994) · JAMA · doi:10.1001/jama.1994.03510270072043 · Cited by 530 · see citing works
Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update
Hollenberg, S. M., Ahrens, T. S., Annane, D., Astiz, M. E., Chalfin, D. B., Dasta, J. F., Heard, S. O., Martin, C., Napolitano, L. M., Susla, G. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000139761.05492.d6 · Cited by 508 · see citing works
Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness.
Gulick, T., Chung, M. K., Pieper, S. J., Lange, L. G., & Schreiner, G. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6753 · Cited by 495 · see citing works
Fink, M. P. (2001) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70161-5 · Cited by 302 · see citing works
Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression
Morelli, A., Castro, S. D., Teboul, J., Singer, M., Rocco, M., Conti, G., Luca, L. D., Angelantonio, E. D., Orecchioni, A., Pandian, N. G., et al. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2619-z · Cited by 301 · see citing works
Yokoshiki, H., Katsube, Y., Sunagawa, M., & Sperelakis, N. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01108-4 · Cited by 300 · see citing works
Gore, D. C., Jahoor, F., Hibbert, J. M., et al. (1996) · Annals of Surgery · doi:10.1097/00000658-199607000-00015 · Cited by 285 · see citing works
Sustained Hemodynamic Effects of Intravenous Levosimendan
Kivikko, M., Lehtonen, L., & Colucci, W. S. (2003) · Circulation · doi:10.1161/01.cir.0000043245.00859.11 · Cited by 258 · see citing works
Vasopressor and inotropic support in septic shock: An evidence-based review
Beale, R. J., Hollenberg, S. M., Vincent, J., & Parrillo, J. E. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000142909.86238.b1 · Cited by 254 · see citing works
Impaired β-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock
SILVERMAN, H. J., PENARANDA, R., Orens, J. B., et al. (1993) · Critical Care Medicine · doi:10.1097/00003246-199301000-00010 · Cited by 223 · see citing works
Catecholamine-induced Changes in the Splanchnic Circulation Affecting Systemic Hemodynamics
Gelman, S., Mushlin, P. S., & Weiskopf, R. B. (2004) · Anesthesiology · doi:10.1097/00000542-200402000-00036 · Cited by 221 · see citing works
Oxygen transport patterns in patients with sepsis syndrome or septic shock
Hayes, M., Timmins, A. C., Yau, E. H. S., Palazzo, M. G. A., Watson, D. I., & Hinds, C. (1997) · Critical Care Medicine · doi:10.1097/00003246-199706000-00007 · Cited by 157 · see citing works
Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock
Oldner, A., Konrad, D., Weitzberg, E., et al. (2001) · Critical Care Medicine · doi:10.1097/00003246-200111000-00022 · Cited by 137 · see citing works
Levosimendan protects against experimental endotoxemic acute renal failure
Zager, R. A., Johnson, A. C. M., Lund, S., et al. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00485.2005 · Cited by 137 · see citing works
Does Hepato-splanchnic V o 2/D o 2 Dependency Exist in Critically Ill Septic Patients?
Backer, D. D., Créteur, J., Noordally, O., Smaïl, N., Gulbis, B., & Vincent, J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9705075 · Cited by 116 · see citing works
Yasuda, S., & Lew, W. Y. W. (1997) · Circulation Research · doi:10.1161/01.res.81.6.1011 · Cited by 116 · see citing works
Clinical manifestations of disordered microcirculatory perfusion in severe sepsis.
Trzeciak, S. W., & Rivers, E. P. (2005) · Critical Care · doi:10.1186/cc3744 · Cited by 111 · see citing works
Transvisceral Lactate Fluxes During Early Endotoxemia
Bellomo, R., Kellum, J. A., & Pinsky, M. R. (1996) · CHEST Journal · doi:10.1378/chest.110.1.198 · Cited by 97 · see citing works
Dobutamine improves gastrointestinal mucosal blood flow in a porcine model of endotoxic shock
Nevière, R., Chagnon, J. L., Vallet, B., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199708000-00026 · Cited by 80 · see citing works
Hiltebrand, L. B., Krejčí, V., & Sigurdsson, G. H. (2004) · Anesthesiology · doi:10.1097/00000542-200405000-00022 · Cited by 78 · see citing works
Backer, D. D., Moraine, J.-J., Berré, J., Kahn, R. J., & Vincent, J. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.1.8025780 · Cited by 75 · see citing works
Leather, H. A., Eycken, K. V., Segers, P., et al. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000084844.95073.c0 · Cited by 71 · see citing works
EVALUATING MYOCARDIAL DEPRESSION IN SEPSIS
Levy, R. J., & Deutschman, C. S. (2004) · Shock · doi:10.1097/01.shk.0000129198.53836.15 · Cited by 69 · see citing works
Chrusch, C., Bands, C. J., Böse, D., et al. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.9902403 · Cited by 69 · see citing works
Treggiari, M. M., Romand, J.-A., Burgener, D., et al. (2002) · Critical Care Medicine · doi:10.1097/00003246-200206000-00032 · Cited by 66 · see citing works
Dubín, A., Murias, G. E., Sottile, J. P., Pozo, M. O., Barán, M., Edul, V. S. K., Canales, H. S., Etcheverry, G., Maskin, B. C., & Estenssoro, E. (2007) · Intensive Care Medicine · doi:10.1007/s00134-006-0519-5 · Cited by 59 · see citing works
Vasopressor Support in Septic Shock
Hollenberg, S. M. (2007) · CHEST Journal · doi:10.1378/chest.07-0291 · Cited by 57 · see citing works
Hemodynamic optimization of sepsis-induced tissue hypoperfusion.
Zanotti-Cavazzoni, S., & Dellinger, R. P. (2006) · Critical Care · doi:10.1186/cc4829 · Cited by 57 · see citing works
Successful reversal of resistent hypodynamic septic shock with levosimendan
Matějovič, M., Kroužecký, A., Raděj, J., et al. (2005) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2005.00541.x · Cited by 39 · see citing works
Optimal Adrenergic Support in Septic Shock Due to Peritonitis
Sun, Q., Tu, Z., Lobo, S. M., et al. (2003) · Anesthesiology · doi:10.1097/00000542-200304000-00015 · Cited by 38 · see citing works
Zhang, H., Jongh, R. D., Backer, D. D., et al. (2001) · Critical Care Medicine · doi:10.1097/00003246-200103000-00020 · Cited by 31 · see citing works
CARDIOVASCULAR EFFECTS OF LEVOSIMENDAN IN THE EARLY STAGES OF ENDOTOXEMIA
Cunha‐Goncalves, D., Perez‐de‐Sá, V., Dahm, P., et al. (2007) · Shock · doi:10.1097/shk.0b013e31804d18f6 · Cited by 29 · see citing works
Self-citationTHE HEPATOSPLANCHNIC CONTRIBUTION TO HYPERLACTATEMIA IN ENDOTOXIC SHOCK: EFFECTS OF TISSUE ISCHEMIA
Créteur, J., Backer, D. D., Sun, Q., & Vincent, J. (2004) · Shock · doi:10.1097/00024382-200405000-00007 · Cited by 22 · see citing works
Dobutamine in elderly septic shock patients refractory to dopamine
Tell, B., Majerus, T. C., & Flancbaum, L. (1987) · Intensive Care Medicine · doi:10.1007/bf00263550 · Cited by 21 · see citing works
Schaffartzik, W., Sanft, C., Schaefer, J. H., et al. (2000) · Intensive Care Medicine · doi:10.1007/s001340000635 · Cited by 21 · see citing works
Norepinephrine administration in septic shock: How much is enough? *
Backer, D. D., & Vincent, J. (2002) · Critical Care Medicine · doi:10.1097/00003246-200206000-00055 · Cited by 18 · see citing works
Cunha‐Goncalves, D., Perez‐de‐Sá, V., Grins, E., et al. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181af3fe3 · Cited by 17 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935 · see citing works
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082 · see citing works
- Authors
- Cunha-Goncalves, D., Perez-de-Sa, V., Larsson, A., Thörne, J., & Blomquist, S.
- Affiliations
- Uppsala University Hospital (SE)
- Helsingborgs lasarett (SE)
- Skåne University Hospital (SE)
- Corresponding author
- Blomquist, Sten
- ORCID
- Larsson, Anders
- Venue
- Anesthesia & Analgesia
- Published
- 2009-11
- Volume
- 109
- Issue
- 5
- Pages
- 1576-1583
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W2024647297
- Cited by
- 24
- References
- 42
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 1 · 2022: 1 · 2021: 3 · 2019: 2 · 2018: 1 · 2016: 1 · 2015: 1 · 2014: 3 · 2013: 1 · 2012: 1
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Anesthesia & Analgesia (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
- Keywords
- levosimendan, dobutamine, inotropic support, norepinephrine, systemic perfusion, cardiac output, systemic vascular resistance, oxygen delivery, lipopolysaccharide, fluid resuscitation, vasopressor comparison, regional blood flow, systemic hypotension
- MeSH terms
- Simendan, Animals, Blood Pressure, Blood Volume, Cardiac Output, Cardiotonic Agents, Combined Modality Therapy, Disease Models, Animal, Dobutamine, Drug Therapy, Combination, Fluid Therapy, Heart Rate, Hemodynamics, Hydrazones, Hypotension, Lipopolysaccharides, Liver Circulation, Norepinephrine, Oxygen, Pyridazines, Regional Blood Flow, Shock, Septic, Splanchnic Circulation, Swine, Time Factors, Vascular Resistance, Lactic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review